Musculoskeletal Disorder clinical trials
17 active trials name this condition. Describe your situation to see which ones look like a fit.
By location
- Mesenchymal Stem Cells for the Treatment of Various Chronic and Acute Conditions
- Ergonomic Protocol for Competitive E-Sport Athletes
- Pre-operative Inspiratory Muscle Strength Training in Total Joint Surgery
- Mode of Exercise and Bone Biomarkers in Older Veterans
- Technical Development of Cardiovascular Magnetic Resonance Imaging (CMR) Using a Low Specific Absorption Rate (SAR) Scanner System
- CERAMENT™| Bone Void Filler Device Registry
- 100-Year Human Aging Study
- Human Observatory Study
- Multi-Vendor Multi-Site Novel Accelerated MRI Relaxometry
- The Effects of AFO Heel Height and Stiffness on Gait
- Right-Size Clinic Visits Using Memora Platform for PROMIS
- Understanding Patient Preferences When Deciding on a Voluntary Musculoskeletal Test
- Use of Osteopathic Manipulative Treatment for Non-musculoskeletal Conditions
- Digital Care Programs for Musculoskeletal Health
- Metallosis on Tissues and Serum Metal Levels in Children
- A Clinical Registry of Orthobiologics Procedures
- Testing an AI Large Language Model Tool for Cognitive Debiasing in Musculoskeletal Care
Guides for people searching for a trial
- Why people get turned down — and what to do nextWhat eligibility criteria are for, what keeps people out, and where to go when the first door closes.
- How your biomarkers decide which trials you qualify forEGFR, HER2, BRAF, PD-L1 and the rest — what they are and why they increasingly gate access.
- How to search for a trial without losing your mindWhere to look, what to gather first, and how to read what you find.
- What Phase 1, 2 and 3 actually mean for youWhat each phase is testing, and how to weigh an early-phase trial against a later one.
- 10 questions to ask before you say yesTreatment, time, cost, safety and your rights. Worth bringing to a screening visit.
- You matched with a trial. What happens now?Phone screens, the screening visit, informed consent, and day one.
Showing active trials that list “Musculoskeletal Disorder” as a condition. Eligibility shown on each trial is an estimate — the trial's study team makes the final decision.